NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.
NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.
复制标题
DOI:
10.1038/nature16969
复制
发表时间:
2016-03-10
期刊:
影响因子:
64.8
通讯作者:
Greten TF
中科院分区:
文献类型:
--
作者:
Ma C;Kesarwala AH;Eggert T;Medina-Echeverz J;Kleiner DE;Jin P;Stroncek DF;Terabe M;Kapoor V;ElGindi M;Han M;Thornton AM;Zhang H;Egger M;Luo J;Felsher DW;McVicar DW;Weber A;Heikenwalder M;Greten TF
Hepatocellular carcinoma (HCC) is the second most common cause of cancer related death. Non-alcoholic fatty liver disease (NAFLD) affects a large proportion of the US population and is considered a metabolic predisposition to liver cancer . However, the role of adaptive immune responses in NAFLD-promoted HCC is largely unknown. Here, we show that dysregulation of lipid metabolism in NAFLD causes a selective loss of intrahepatic CD4+ but not CD8+ T lymphocytes leading to accelerated hepatocarcinogenesis. We also found that CD4+ T lymphocytes have greater mitochondrial mass than CD8+ T lymphocytes and generate higher levels of mitochondrially-derived reactive oxygen species (ROS). Disruption of mitochondrial function by linoleic acid, a fatty acid accumulated in NAFLD, causes more oxidative damage than other free fatty acids such as palmitic acid, and mediates selective loss of intrahepatic CD4+ T lymphocytes. In vivo blockade of ROS reversed NAFLD-induced hepatic CD4+ T lymphocyte decrease and delayed NAFLD-promoted HCC. Our results provide an unexpected link between lipid dysregulation and impaired anti-tumor surveillance.